HomeBusiness NewsKaruna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

- Advertisement -spot_imgspot_img

Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash…

- Advertisement -spot_imgspot_img
Stay Connected
16,985FansLike
4,568FollowersFollow
Must Read
Related News

LEAVE A REPLY

Please enter your comment!
Please enter your name here